FDA Approves NUMELVI™ (atinvicitinib tablets) for Dogs

The United States Food and Drug Administration has approved NUMELVI™ (atinvicitinib tablets), a new treatment for itch associated with allergic dermatitis in dogs, developed by Merck Animal Health. The company says the medication is the first and only second-generation Janus kinase (JAK) inhibitor approved in the United States for this indication.